Whittier Street Health Center

United States
West Roxbury, Massachusetts, United States, 02120

Company profile

Whittier Street Health Center company profile

Whittier Street Health Center (WSHC) is a comprehensive, innovative and high quality health care and wellness center championing equitable access to high quality, cost-effective health care for diverse populations. WSHC is accredited by The Joint Commission (TJC), certified by the NCQA as a golden level (highest ranking) patient centered medical home and licensed by the Massachusetts Department of Public Health (DPH). The vision of the Whittier Street Health Center is to serve as the premiere health center for Boston residents and the mission is to provide high quality, reliable and accessible primary care and support services to promote wellness and eliminate health and social disparities. Located in the Roxbury neighborhood of Boston, Whittier Street Health Center provides comprehensive health services including primary care, behavioral health care, substance abuse services, dental care and eye care to over 25,000 patients. A trusted member of the community for 80 years, Whittier is here to provide the care that you and your family need to get healthy and stay healthy. We provide many services to help raise it out of poverty and into a place of good health. Having translators for 17 languages and utilizing clinical and social services to meet specific community needs through outreach, targeted programs and state of the art health care delivery helps us stay connected with the community.

Business identity

Contact email
[email protected]
Phone number
(617) 427-1000
Operating status
Active
Company type
For Profit
Employee range
251-500 employees
Revenue range
$1M-$10M
Founded
1933-01-01, Year

Headquarters

Postal code
02120
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
2
Last funding
Grant / $500,000 / 2023-02-07
Investors
2
Lead investors
1
Articles
25

Founders and investors

Lead investors

U.S. Department of Health & Human Services

Investors

AstraZenecaU.S. Department of Health & Human Services